Transurethral resection of the prostate is the current gold standard treatment for benign prostatic hyperplasia (BPH); however, the risks and complications associated with this procedure correlate ...

SSM Health Saint Louis University Hospital recently performed the first transurethral ultrasound ablation ... invasive procedure that uses directional ultrasound to produce very high temperatures to ...

Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

Men seeking urologic care, either through self-referral or clinician referral, often have knowledge gaps in BPH symptoms and treatment.

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in 2024 and an ...

SSM Health Saint Louis University Hospital (SLU-H) is the first and only hospital in Missouri and the larger Midwest region to perform a new innovative and less-invasive prostate cancer procedure. The ...

and D90 (percent of the prescribed dose that at least 90% of the prostate received) were averaged for a random sample of 25 patients each in the androgen ablation and no-androgen ablation groups ...